KidneySmall kidney tumoursTreatment choices

Cryoablation or partial nephrectomy? Choosing treatment for a small kidney tumour

Freezing the tumour or removing it while keeping the rest of the kidney: an honest comparison of the procedure, recovery and cancer control, and the questions to ask when the choice is yours.

By Mr Denosshan Sri, Consultant Urological Surgeon November 2026 9 min read
Choosing between cryoablation and partial nephrectomy for a small kidney tumour
In this article
  1. What a small kidney tumour is
  2. Watch, freeze or remove
  3. How the two procedures differ
  4. Side by side
  5. Recovery
  6. Cancer control
  7. Who each option suits
  8. Questions to ask

Being told you have a kidney tumour is a frightening moment, and it usually arrives with more than one option attached. For a small tumour you may be offered active surveillance, cryoablation, or surgery to remove just the affected part of the kidney.

This article compares the two treatments people most often ask me about, cryoablation and robotic partial nephrectomy, and sets out the trade-offs honestly, so you can take part in the decision rather than simply receive it.

What a small kidney tumour is

A kidney tumour is a growth in one of your kidneys. Most are now found by chance, on a scan done for another reason, and until tests confirm what it is, it is often called a renal mass.

"Small" usually means under about 4cm, which is classed as a T1a tumour (kidney cancer staging explained). Many small kidney tumours are cancers, but they tend to grow slowly and are often cured when treated, and around one in five turn out not to be cancer at all. The word cancer still lands hard, and it is reasonable to feel anxious. The important point is that a tumour this size usually gives you time to choose well.

Why watch, freeze or remove can all be reasonable

Because small tumours grow slowly and rarely spread at this size, not treating straight away is a genuine option for some people, especially if you are older or have other health conditions. This is active surveillance: regular scans, with treatment held back unless the tumour changes.

Freezing the tumour (cryoablation) and removing the tumour while sparing the rest of the kidney (partial nephrectomy) are the two main ways to treat it actively. All three can be reasonable. My article on the best treatment for a 3cm kidney tumour looks at all the options together.

How the two procedures differ

Both treatments share the same aim: to deal with the tumour while protecting as much healthy kidney as possible. They get there in very different ways.

Cryoablation: freezing the tumour

Cryoablation destroys the tumour by freezing it. It is usually performed by an interventional radiologist, who passes one or more thin needles through the skin into the tumour, guided by a CT scan. There is no surgical cut. Extremely cold gas freezes the tumour and a margin of tissue around it, and that tissue then dies and is gradually absorbed.

It is done under sedation or a general anaesthetic, and many people go home the same day or the next morning. Because there is no wound, recovery is usually quick. A biopsy of the tumour is normally taken before or at the time of treatment, because once the tumour is frozen it cannot be examined under the microscope.

Robotic partial nephrectomy: removing the tumour

A partial nephrectomy removes the tumour together with a thin rim of healthy tissue, leaving the rest of the kidney working. In robotic surgery, I operate through small keyhole incisions with instruments that bend and rotate inside the body, under a magnified 3D view.

That precision matters most when the tumour sits close to the blood vessels or the kidney's drainage system, and when the time the blood supply is clamped needs to be kept as short as possible to protect kidney function. For tumours at the back of the kidney, I often use a retroperitoneal approach, which reaches the kidney from behind without entering the abdomen. It is a bigger undertaking than ablation, with a hospital stay of usually one to two nights.

Side by side

CryoablationRobotic partial nephrectomy
How it worksFreezes the tumour through needles in the skinRemoves the tumour through keyhole cuts
Hospital stayOften a day case or one nightUsually one to two nights
Back to normalUsually within daysUsually two to four weeks
Confirms the diagnosisOnly by a biopsy beforehandYes: the whole tumour and its margin are examined
Chance of a second treatmentHigher, especially for larger tumoursLow
Best suited toSmaller tumours, often under 3cm, away from the drainage system and bowelMost small tumours, including complex or central ones
Follow-upRegular scansRegular scans

Recovery: what to expect

Recovery is where the two treatments differ most.

  • After cryoablation, most people are back to normal activities within a few days and back to work within a week or so. The needle sites are usually a little sore for a day or two.
  • After robotic partial nephrectomy, expect to feel tired for a week or two, to return to desk-based work after two to three weeks, and to avoid heavy lifting for around four to six weeks. My week-by-week recovery guide explains what each stage feels like.

Neither treatment is free of risk. A small number of people have bleeding, infection or a urine leak after surgery. After ablation, a small amount of tumour can survive the freeze and need a second treatment. Being honest about these risks is part of choosing well.

There is rarely one single right answer. There is usually a best answer for you.

Cancer control: what the evidence shows

For small tumours, both treatments give very good long-term results, and the chance of the cancer spreading or shortening life is low with either. The difference lies mainly in the risk of the tumour coming back in the same place.

  • Partial nephrectomy has the longest track record. The removed tissue is examined under a microscope, which confirms exactly what the tumour was and whether its edge, the margin, is clear.
  • Cryoablation avoids an operation, but the tissue is destroyed where it lies, so there is no margin to check. Local recurrence is more common than after surgery, particularly as tumours get larger. Most recurrences are picked up on follow-up scans and can be treated with a repeat ablation or surgery.

European urology guidelines recommend partial nephrectomy as the standard treatment for small kidney tumours where it is technically feasible, with ablation as a good alternative for selected patients, particularly those with smaller tumours, older people and those with other health conditions that make surgery riskier.

Your kidney function matters too. Both treatments are designed to preserve as much working kidney as possible, which lowers the long-term risk of kidney problems, especially if you already have reduced kidney function, diabetes or high blood pressure.

Robotic partial nephrectomy in my practice

I lead the NHS kidney cancer service for South West London, and accept referrals for tumours that other centres have judged unsuitable for kidney-sparing surgery. From my audited robotic series:

97%trifecta rate in robotic partial nephrectomy
<1%positive margin rate
0%conversion to open surgery
48%of tumours I treat with kidney preservation have a RENAL score of 10 or more

Audited robotic series to the end of 2025. Trifecta: clear margins, no major complications and warm ischaemia under 25 minutes. See all outcomes

Who each option tends to suit

Every decision is individual and should be made with a multidisciplinary team (MDT) of urologists, radiologists and oncologists reviewing your scans together. As a general guide:

  • Cryoablation often suits smaller tumours (typically under 3cm) on the outer part of the kidney, older people, and those whose heart, lung or other conditions make an operation riskier.
  • Partial nephrectomy often suits younger, fitter people, larger tumours, and tumours that sit deep in the kidney or close to its drainage system or major blood vessels, where freezing is less reliable or risks damage. My article on what a high RENAL score means explains how surgeons judge a tumour's complexity.
  • Active surveillance often suits very small tumours, older people, or anyone for whom the risks of any treatment outweigh the benefits.

Worth knowing: cryoablation and partial nephrectomy are often offered by different specialists, an interventional radiologist and a urological surgeon. If you are only hearing about one option, it is reasonable to ask to hear the case for the other.

Weighing up your options? A second opinion can help you decide between surveillance, ablation and surgery.
About second opinions

Questions to ask when the choice is yours

Screenshot or print this list and take it with you. Bring someone with you if you can, and ask them to write down the answers.

  1. How big is the tumour, and exactly where does it sit in the kidney?
  2. Would active surveillance be a reasonable option for me?
  3. Is my tumour one where both ablation and surgery would work well?
  4. Will a biopsy be taken, and when?
  5. What is my current kidney function, and how might each option affect it?
  6. How likely is it, in my case, that the first treatment deals with the tumour completely?
  7. Who would perform each treatment, and has the MDT reviewed my scans?
  8. What does recovery look like for someone with my job and home life?
  9. What follow-up scans will I need, and for how long?

You don't have to decide alone, or in a hurry

A small kidney tumour almost always allows time to think, ask questions and talk it through with the people close to you. Both cryoablation and robotic partial nephrectomy are good treatments. The right one is the one that fits your tumour, your health and what matters most to you.

If you've only just been told about a kidney lump, kidney cyst vs kidney tumour explains what scans can and can't tell you.

Mr Denosshan Sri
Mr Denosshan Sri
MA Cantab, MB BChir, FRCS Urol. GMC 7140360

Consultant Urological Surgeon and NHS Kidney Cancer Lead for South West London at St George's University Hospital, specialising in robotic kidney and prostate cancer surgery, including complex kidney-sparing surgery. Full profile